Main Menu
About
Overview
Amgen History
Mission and Values
Leadership
Awards and Accolades
How We Operate
Overview
Corporate Governance
Business Ethics and Compliance
Policies, Practices and Disclosures
Science
Overview
Research and Development Strategy
Pipeline
Scientific Advisory Boards
Amgen Science
Amgen Competitive Grants
Biosimilars
Clinical Trials
Overview
About Clinical Trails
Amgen Clinical Trails
Clinical Trial Diversity
Information for Healthcare Professionals
Clinical Trial Transparency, Data Sharing and Disclosure Practices
Clinical Out-of-Hours Support program
Investigator Sponsored Studies
Scientific Community Initiatives
Overview
Educational Outreach Program
Postdoctoral Fellows Program
Scientific Conferences Program
Start-Up Network Program
Manufacturing
Overview
Innovation
Quality
Reliability
PRODUCTS
Overview
Medical Information
Counterfeit Drug Statement
Safety Data Sheets
Global Patient Safety
Overview
Who We Are
Our Commitment
What We Do
Adverse Event and Product Complaint Reporting
Responsibility
Overview
2019 Responsibility Highlights Report
Corporate Responsibility
Strategy & Governance
Overview
Amgen’s Commitment to Patients
Our Approach to Pricing,
Access and Affordability
Access Approaches, Treatments, and Collaborations
Transformative Treatments, Approaches, and Technology
Shaping the Future of Healthcare
Access to Medicine
U.S. Reimbursement Support Services and Financial Assistance Programs
Access to Medicines Initiatives Outside the U.S.
Access to Investigational Medicines
Amgen Foundation
Overview
About the Amgen Foundation
Amgen Foundation Grants
Programs for Teachers
Programs for Students
About the Amgen Foundation
Commitment to Community
Overview
Staff Engagement Programs
Independent Medical Education Funding
U.S. Healthcare Donations
Non-Healthcare Donations and Sponsorships
Equipment Donations
Donation and Grant Recipients
Diversity, Inclusion and Belonging
Amgen's Commitment to Diversity, Inclusion and Belonging
Environment
Overview
Performance
2027 Plan
Sustainable by Design
Case Studies
Responsible Sourcing
Supplier Diversity
Supplier Sustainability
Workplace
Safety
Wellness
Reporting and Metrics
Overview
Archived Reports
Summary of Data
CDP
Stakeholder Engagement
Stories
All Stories
Responsibility
People and Culture
Science and Innovation
Patients
Leadership
Popular Tags
COVID-19
Supporting Our Staff
Leveraging Our Science
Serving Our Communities
Newsroom
Partners
Investors
Careers
Amgen Worldwide
All Stories
Responsibility
People and Culture
Science and Innovation
Patients
Leadership
Popular Tags
COVID-19
Supporting Our Staff
Leveraging Our Science
Serving Our Communities
About
Overview
Amgen History
Mission and Values
Leadership
Awards and Accolades
How We Operate
Corporate Governance
Business Ethics and Compliance
Policies, Practices and Disclosures
Science
Overview
Research and Development Strategy
Pipeline
Scientific Advisory Boards
Amgen Science
Amgen Competitive Grants
Biosimilars
Clinical Trials
About Clinical Trials
Amgen Clinical Trials
Clinical Trial Diversity
Information for Healthcare Professionals
Clinical Trial Transparency, Data Sharing and Disclosure Practices
Clinical Out-of-Hours Support Program
Investigator Sponsored Studies
Scientific Community Initiatives
Educational Outreach Program
Postdoctoral Fellows Program
Scientific Conferences Program
Start-Up Network Program
Manufacturing
Innovation
Quality
Reliability
PRODUCTS
Overview
Medical Information
Counterfeit Drug Statement
Safety Data Sheets
Global Patient Safety
Who We Are
Our Commitment
What We Do
Adverse Event and Product Complaint Reporting
Responsibility
Overview
2019 Responsibility Highlights Report
Corporate Responsibility Strategy & Governance
Amgen's Commitment to Patients
Our Approach to Pricing, Access and Affordability
Access Approaches, Treatments, and Collaborations
Transformative Treatments, Approaches and Technology
Shaping the Future of Healthcare
Access to Medicine
U.S. Reimbursement Support Services and Financial Assistance Programs
Access to Medicines Initiatives Outside the U.S.
Access to Investigational Medicines
Amgen Foundation
Amgen Inspires
About the Amgen Foundation
Programs for Teachers
Programs for Students
Amgen Foundation Grants
Commitment to Community
Staff Engagement Programs
Independent Medical Education Funding
U.S. Healthcare Donations
Non-Healthcare Donations and Sponsorships
Equipment Donations
Donation and Grant Recipients List
Diversity, Inclusion & Belonging
Amgen's Commitment to Diversity, Inclusion and Belonging
Environment
Performance
2027 Plan
Sustainable by Design
Case Studies
Responsible Sourcing
Supplier Diversity
Supplier Sustainability
Workplace
Safety
Wellness
Reporting and Metrics
Summary of Data
CDP
Stakeholder Engagement
Archived Reports
Stories
All Stories
Responsibility
People and Culture
Science and Innovation
Patients
Leadership
Popular Tags
COVID-19
Supporting Our Staff
Leveraging Our Science
Serving Our Communities
Newsroom
Partners
Investors
Careers
X
Home
>
Stories
>
Leadership
>
Leadership Stories
LEADERSHIP
12.17.2020
Amgen CEO: Greater U.S.-China Collaboration Will Accelerate Fight Against Cancer
Read more
All Stories
All
PATIENTS
RESPONSIBILITY
LEADERSHIP
SCIENCE & INNOVATION
PEOPLE & CULTURE
All
PATIENTS
RESPONSIBILITY
LEADERSHIP
SCIENCE & INNOVATION
PEOPLE & CULTURE
LEADERSHIP
12.17.2020
Amgen CEO: Greater U.S.-China Collaboration Will Accelerate Fight Against Cancer
LEADERSHIP
12.16.2020
Amgen Ranks 26th on Wall Street Journal’s List of Best-Managed Companies
LEADERSHIP
12.14.2020
Amgen CEO Bob Bradway Highlights Advances Against COVID-19 and Other Diseases at Major Healthcare Conferences
LEADERSHIP
11.20.2020
Amgen's Clean Sweep in the 2021 All-America Executive Team Rankings
LEADERSHIP
11.17.2020
A Conversation on Social Justice: Amgen’s CEO and Echoing Green’s President
LEADERSHIP
11.10.2020
5 Important Steps for Advancing Health Equity
LEADERSHIP
10.30.2020
CEO Bob Bradway Praises Manufacturing Teams in Puerto Rico Focused on Patient Supply
LEADERSHIP
10.21.2020
Where Biosimilars Are Headed in the U.S.
LEADERSHIP
10.20.2020
At Milken Global Conference, Amgen CEO Bob Bradway Urges More Attention to Predicting and Preventing Chronic Disease Amid COVID-19 Pandemic
LEADERSHIP
10.05.2020
Coming Together to Advance Healthcare Equity
LEADERSHIP
10.05.2020
"The World Recognizes We Need Innovation to Defeat COVID-19": Bradway Speaks at Financial Times Conference
LEADERSHIP
09.24.2020
Susan Sweeney: Five Things We Must Do To Improve the Healthcare System
LEADERSHIP
09.16.2020
Reflecting on Hispanic Heritage Month with Nancy Grygiel and Edda Colon
LEADERSHIP
09.14.2020
Meet Amgen’s New Chief Compliance Officer – Nancy A. Grygiel
LEADERSHIP
08.03.2020
Amgen CEO to Interns: Stay Curious, Keep Learning, Make a Difference
LEADERSHIP
07.16.2020
CEO Bob Bradway Discusses Industry’s COVID-19 Response at
Fortune
Conference
LEADERSHIP
06.09.2020
Dr. David Reese Discusses Amgen’s COVID-19 Work at ‘WSJ Tech Health’ Event
LEADERSHIP
05.31.2020
CEO Bob Bradway Shares Perspective on Death of George Floyd
LEADERSHIP
05.20.2020
Science, Execution, and COVID-19 Response Highlighted at Annual Stockholder Meeting
LEADERSHIP
04.28.2020
“Now More Than Ever, We Need to Lean In”
Load more
Loading...